Amzak Health Investors logo

Amzak Health Investors

North America, New York, United States, New York

Description

Amzak Health Investors invests across the healthcare sector including therapeutics, devices, diagnostics, and services.

Investor Profile

Amzak Health Investors has made 20 investments, with 3 in the past 12 months and 35% as lead.

Stage Focus

  • Series B (40%)
  • Series A (25%)
  • Post Ipo Equity (10%)
  • Series C (10%)
  • Series D (10%)
  • Series Unknown (5%)

Country Focus

  • United States (70%)
  • Canada (20%)
  • Switzerland (10%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Medical Device
  • Therapeutics
  • Biopharma
  • Clinical Trials
  • Wellness
  • Pharmaceutical
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Amzak Health Investors frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 3
CA
North America, Massachusetts, United States, Boston
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
Casdin Capital
North America, New York, United States, New York
Co-Investments: 3
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 5
CAM Capital
North America, New York, United States, New York
Co-Investments: 3
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 3
Sixty Degree Capital
North America, Ontario, Canada, Toronto
Co-Investments: 4
Aisling Capital
North America, New York, United States, New York
Co-Investments: 6

Which angels does Amzak Health Investors often collaborate with?

Shared Deals: 1

What are some of recent deals done by Amzak Health Investors?

Sound Blade Medical

Halifax, Nova Scotia, Canada

Sound Blade Medical is an early stage medical device startup which transforms healthcare by developing endoscopic, image-guided histotripsy.

Health CareMedicalMedical Device
Series AJan 29, 2025
Amount Raised: $16,500,000
ShiraTronics

Minneapolis, Minnesota, United States

ShiraTronics develops neuromodulation technology to combat debilitating chronic migraine.

Clinical TrialsHealth CareMedical Device
Series BSep 30, 2024
Amount Raised: $66,000,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series DAug 15, 2024
Amount Raised: $102,000,000
Synergy Disc Replacement Inc

Cambridge, Ontario, Canada

Synergy Disc Replacement Inc(SDRI) produces Cervical disc implant to restore patient's balance, range of motion and alignment.

Health Care
Series AJan 31, 2024
Amount Raised: $30,000,000
Gynesonics

Redwood City, California, United States

Gynesonics develops transcervical, uterus-preserving, incision-less technologies for diagnostic and therapeutic applications.

Health CareMedicalMedical DeviceWomen's
Series UnknownOct 25, 2023
Amount Raised: $42,500,000
Miach Orthopaedics

Boston, Massachusetts, United States

Miach Orthopaedics is a medical device company that designs technologies intended to facilitate new tissue growth.

BiotechnologyHealth CareManufacturingMedicalMedical DeviceWellness
Series BJan 25, 2023
Amount Raised: $30,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BNov 3, 2021
Amount Raised: $75,000,000
Thryv Therapeutics

Laval, Quebec, Canada

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

BiotechnologyPrecision MedicineTherapeutics
Series AAug 10, 2021
Amount Raised: $19,000,000
Antios Therapeutics

Atlanta, Georgia, United States

Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.

BiopharmaBiotechnologyTherapeutics
Series BApr 12, 2021
Amount Raised: $96,000,000
Monte Rosa Therapeutics

Basel, Basel-Stadt, Switzerland

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

BiotechnologyMedicalTherapeutics
Series CMar 12, 2021
Amount Raised: $95,000,000